AbbVie Stock

AbbVie Inventory

The Inventory of AbbVie (ABBV) as of Sep 15, 2026 is 4.95 B USD. In the previous year, Inventory was 4.18 B USD — a change of 18.42% (higher).

Inventory

4.95 BUSD

YoY

18.42%

Last updated:

Inventory of AbbVie is 2026 4.95 B USD. Inventory of AbbVie was 2025 4.18 B USD. It decreases by 18.42% higher compared to the previous year.

The AbbVie Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
1.61 B USD
Jan 1, 2019
1.81 B USD
Jan 1, 2020
3.31 B USD
Jan 1, 2021
3.13 B USD
Jan 1, 2022
3.58 B USD
Jan 1, 2023
4.10 B USD
Jan 1, 2024
4.18 B USD
Jan 1, 2025
4.95 B USD
The AbbVie Inventory history
YEARInventoryYoY
4.95 BUSD+18.42%
4.18 BUSD+2.00%
4.10 BUSD+14.53%
3.58 BUSD+14.42%
3.13 BUSD-5.50%
3.31 BUSD+82.57%
1.81 BUSD+12.96%
1.61 BUSD0.00%
1.61 BUSD+11.15%
1.44 BUSD-16.00%
1.72 BUSD+52.94%
1.12 BUSD—
Access this data via the Eulerpool API
Get Free API Key

AbbVie Stock analysis

What does AbbVie do? Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines. AbbVie is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AbbVie stock

Inventory of AbbVie is 4.95 B USD in 2026.

Inventory of AbbVie changed from 4.18 B USD to 4.95 B USD, representing a 18.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory AbbVie since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's AbbVie historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — AbbVie

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — AbbVie